DE69711773T2 - Ovulation auslösende arzneistoffe enthaltend luteinisierendes hormon - Google Patents

Ovulation auslösende arzneistoffe enthaltend luteinisierendes hormon

Info

Publication number
DE69711773T2
DE69711773T2 DE69711773T DE69711773T DE69711773T2 DE 69711773 T2 DE69711773 T2 DE 69711773T2 DE 69711773 T DE69711773 T DE 69711773T DE 69711773 T DE69711773 T DE 69711773T DE 69711773 T2 DE69711773 T2 DE 69711773T2
Authority
DE
Germany
Prior art keywords
ovulation
products containing
luteinizing hormone
medicinal products
releasing medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69711773T
Other languages
English (en)
Other versions
DE69711773D1 (de
Inventor
Jean-Claude Emperaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Application granted granted Critical
Publication of DE69711773D1 publication Critical patent/DE69711773D1/de
Publication of DE69711773T2 publication Critical patent/DE69711773T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Steroid Compounds (AREA)
DE69711773T 1996-02-02 1997-01-31 Ovulation auslösende arzneistoffe enthaltend luteinisierendes hormon Expired - Lifetime DE69711773T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9601303A FR2744367B1 (fr) 1996-02-02 1996-02-02 Medicaments pour le declenchement de l'ovulation
PCT/FR1997/000198 WO1997027868A1 (fr) 1996-02-02 1997-01-31 Medicaments pour le declenchement de l'ovulation

Publications (2)

Publication Number Publication Date
DE69711773D1 DE69711773D1 (de) 2002-05-16
DE69711773T2 true DE69711773T2 (de) 2002-11-21

Family

ID=9488791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69711773T Expired - Lifetime DE69711773T2 (de) 1996-02-02 1997-01-31 Ovulation auslösende arzneistoffe enthaltend luteinisierendes hormon

Country Status (11)

Country Link
US (1) US6407057B1 (de)
EP (1) EP0819009B1 (de)
JP (1) JPH11503466A (de)
AT (1) ATE215834T1 (de)
CA (1) CA2218398A1 (de)
DE (1) DE69711773T2 (de)
DK (1) DK0819009T3 (de)
ES (1) ES2174216T3 (de)
FR (1) FR2744367B1 (de)
PT (1) PT819009E (de)
WO (1) WO1997027868A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL369021A1 (en) * 2001-09-12 2005-04-18 Applied Research Systems Ars Holding N.V. Use of hcg and lh in controlled ovarian hyperstimulation
EP1471891A4 (de) * 2002-02-08 2007-04-11 Alkermes Inc Zusammensetzungen auf polymerbasis mit verzögerter freisetzung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1197570B (it) * 1983-02-11 1988-12-06 Serono Ist Farm Miscele di fsh e lh da ipofisi porcine in rapporto definito
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
NZ216122A (en) 1985-05-10 1989-07-27 Univ Melbourne Stimulating ovulation in mares by administering gonadotrophin-releasing hormones
MY107937A (en) * 1990-02-13 1996-06-29 Takeda Chemical Industries Ltd Prolonged release microcapsules.
NO302481B1 (no) * 1990-10-16 1998-03-09 Takeda Chemical Industries Ltd Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
US5356876A (en) * 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy

Also Published As

Publication number Publication date
JPH11503466A (ja) 1999-03-26
WO1997027868A1 (fr) 1997-08-07
CA2218398A1 (fr) 1997-08-07
DK0819009T3 (da) 2002-08-05
FR2744367A1 (fr) 1997-08-08
FR2744367B1 (fr) 1999-07-09
ES2174216T3 (es) 2002-11-01
PT819009E (pt) 2002-09-30
ATE215834T1 (de) 2002-04-15
DE69711773D1 (de) 2002-05-16
EP0819009A1 (de) 1998-01-21
US6407057B1 (en) 2002-06-18
EP0819009B1 (de) 2002-04-10

Similar Documents

Publication Publication Date Title
EP0654973A4 (de) Anordnung zur abgabe von medikamenten an das lymphgewebe.
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
FI930862A (fi) En doseringsform foer tidsvarierande moenster av laekemedeloeverlaotelse
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
KR970702720A (ko) 항간질 약물에 효과적인 제형(Effectice Dosage Form for Antiepileptic Drugs)
WO1994027589A3 (en) Antidepressant dosage form
PL297747A1 (en) Prolonged action pharmaceutical dosage forms
GB9806632D0 (en) Peptide factor
EP0652770A4 (de) Orale gabe von antigenen.
MX9804395A (es) Proceso y equipo anticonceptivos para mamiferos hembra, que comprenden una combinacion de gestageno y estrogeno.
ZA968715B (en) Stable pharmaceutical forms of administration containing parathyroid hormone.
NL930103I2 (nl) Nonapeptide- en decapeptidederivaten van tot afgifte van luteiniserend hormoon aanzettend hormoon, bereiding daarvan en farmaceutische preparaten, di e deze bevatten.
NZ237930A (en) Wafer for administration of medicaments through the sub-lingual mucosa
ES2101317T3 (es) Medicamento para aumentar el nivel de testosterona.
GB9414966D0 (en) Pharmaceutical compositions for the nasal administration of antiviral agents
BG101427A (en) Competitive progesterone antagonists for regulating female fertility as required
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
FR2651435B1 (de)
ZA925146B (en) Pharmaceutical agent for treatment of withdrawal symptoms.
DE69711773D1 (de) Ovulation auslösende arzneistoffe enthaltend luteinisierendes hormon
MD970244A (en) Dimer lysozime new application
PL348202A1 (en) Pharmaceutically active composition and dispensing device
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
ZA963714B (en) Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours.
RU93058365A (ru) Пептидные соединения и содержащее их лекарственное средство

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH